Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 641 - 660 results of 12,841 for search '(( significantly increased decrease ) OR ( significant ((nn decrease) OR (greatest decrease)) ))*', query time: 0.53s Refine Results
  1. 641
    Conditional deletion of C/EBP in epidermis results in downregulation of transcripts and pathways associated with lipid biosynthesis in epidermis.

    Conditional deletion of C/EBP in epidermis results in downregulation of transcripts and pathways associated with lipid biosynthesis in epidermis. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 642
    UHPLC-MS CKO vs K5Cre results.

    UHPLC-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 643
    Uncropped raw western blot images.

    Uncropped raw western blot images. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 644
    LC-IMS-CID-MS CKO vs K5Cre results.

    LC-IMS-CID-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 645
    Fatty acids, triacylglycerol and ketone body metabolism CKO vs K5Cre Reactome.

    Fatty acids, triacylglycerol and ketone body metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 646
    Phospholipid metabolism CKO vs K5Cre Reactome.

    Phospholipid metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 647
    Cholesterol biosynthetic process CKO vs K5Cre GO: Biological Processes.

    Cholesterol biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 648
    Targeted analysis of cholesterol and cholesterol esters in epidermis reveals changes in specific cholesterol esters in CKO epidermis.

    Targeted analysis of cholesterol and cholesterol esters in epidermis reveals changes in specific cholesterol esters in CKO epidermis. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 649
    Localization and conditional deletion of C/EBP in SKH1 mouse epidermis.

    Localization and conditional deletion of C/EBP in SKH1 mouse epidermis. by Kevin J. Mills (9270966)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 650
    Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013.

    Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 651
    The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019.

    The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 652
    Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019.

    Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 653
    Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019.

    Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 654
    ROBINS-I assessments.

    ROBINS-I assessments. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 655
    S8 File -

    S8 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 656
    Study populations of included studies.

    Study populations of included studies. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 657
    Future research directions.

    Future research directions. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 658
    PRISMA flow diagram.

    PRISMA flow diagram. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 659
    Exercise protocols and results of included studies.

    Exercise protocols and results of included studies. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 660
    Participant characteristics in studies of children with biopsy-proven NAFLD.

    Participant characteristics in studies of children with biopsy-proven NAFLD. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: